Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk’s obesity injection Wegovy and diabetes counterpart Ozempic.
#stockmarket #breaking
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss – CNBC
